Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the period of May 2024, with a filing date of May 22, 2024. The report serves to notify shareholders of the upcoming Annual General Meeting of Shareholders scheduled for June 26, 2024, at 3:00 p.m. Israel time at the Company's offices in Ramat Gan, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding shareholder meeting logistics and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The document focuses solely on the administrative details of the Annual General Meeting.
Guidance, Outlook, and Management Commentary
There is no financial guidance, outlook, or management commentary regarding business operations in this filing. The document provides procedural details for voting, including:
- Submission of a Notice and Proxy Statement (Exhibit 99.1).
- Provision of a Proxy Card for ordinary share holders (Exhibit 99.2).
- Provision of a Voting Instruction Card for American Depositary Shareholders (Exhibit 99.3).
Key Facts for Investor Verification
- Meeting Date: June 26, 2024.
- Meeting Time: 3:00 p.m. Israel time.
- Location: 26 Ben Gurion Street, Ramat Gan, Israel.
- Voting Materials: Shareholders must refer to the attached exhibits for proxy and voting instruction forms.
- Financial Data: This filing contains no financial results; investors should refer to the most recent Form 20-F or quarterly reports for financial metrics.